EQ Company Profile and Key Details

Q: Who are the executives of EQ?

Ms. Maple Fung M.D.Chief Medical OfficerDr. Stephen Connelly Ph.D.Chief Scientific Officer & DirectorMr. Jason A. KeyesChief Financial OfficerDr. Krishna R. Polu M.D.ConsultantMr. Daniel Mark BradburyExecutive ChairmanMatthew Ritter Ph.D.Senior Vice President of Corporation Devel.Mr. Bruce D. Steel C.F.A.Co-Founder, Pres, Chief Executive Officer & DirectorMs. Christine Zedelmayer M.B.A., P.M.P.Senior Vice President & Chief Operating OfficerMr. Joel M. RothmanChief Devel. Officer

NASDAQ : EQ

Equillium

$1.92

0.1+5.49%

At Close 4:00 PM

62.42

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Equillium, Inc. (EQ) stock surged +5.49%, trading at $1.92 on NASDAQ, up from the previous close of $1.82. The stock opened at $1.73, fluctuating between $1.71 and $1.94 in the recent session.

Stock Snapshot

1.82

Prev. Close

68.2M

Market Cap

1.71

Day Low

-3.31

P/E Ratio

-0.58

EPS (TTM)

-0.62

Cash Flow per Share

1.73

Open

35.52M

Number of Shares

1.94

Day High

49.39%

Free Float in %

0.64

Book Value

270.04K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 02, 2026	1.78	1.94	1.71	1.92	270.07K
Feb 27, 2026	1.69	1.84	1.68	1.82	273.28K
Feb 26, 2026	1.83	1.87	1.62	1.74	464.88K
Feb 25, 2026	1.94	1.94	1.82	1.83	287.69K
Feb 24, 2026	1.85	1.97	1.83	1.92	266.7K
Feb 23, 2026	1.70	1.85	1.69	1.85	249.84K
Feb 20, 2026	1.83	1.83	1.71	1.74	220.8K
Feb 19, 2026	1.70	1.87	1.61	1.82	685.92K
Feb 18, 2026	1.58	1.71	1.54	1.70	421.73K
Feb 17, 2026	1.58	1.64	1.55	1.59	220.19K
Feb 13, 2026	1.61	1.65	1.53	1.57	266.39K
Feb 12, 2026	1.55	1.69	1.55	1.60	654.83K
Feb 11, 2026	1.53	1.58	1.49	1.55	443.1K
Feb 10, 2026	1.51	1.59	1.49	1.52	409.61K
Feb 09, 2026	1.55	1.61	1.49	1.50	413.76K
Feb 06, 2026	1.49	1.61	1.49	1.52	742.7K
Feb 05, 2026	1.47	1.50	1.41	1.48	565.61K
Feb 04, 2026	1.53	1.55	1.47	1.51	523.25K
Feb 03, 2026	1.51	1.57	1.47	1.51	333.03K
Feb 02, 2026	1.40	1.56	1.40	1.51	1.11M

Contact Details

La Jolla, CA 92037

United States

https://equilliumbio.com 858 412 5302

About Company

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Stock Peers

REGN

9.14+1.17%

Regeneron Pharmaceuticals, Inc.$790.81 ARGX

-10.16-1.32%

argenx SE$756.76 UTHR

9.92+1.97%

United Therapeutics Corporation$513.82 VRTX

-10.8-2.17%

Vertex Pharmaceuticals Incorporated$486.03 MDGL

3.62+0.84%

Madrigal Pharmaceuticals, Inc.$435.62 PRAX

-6.16-1.83%

Praxis Precision Medicines, Inc.$330.59 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-7.85-2.36%

Alnylam Pharmaceuticals, Inc.$325.07 KRYS

-16.83-6.11%

Krystal Biotech, Inc.$258.81 ASND

8.59+3.68%

Ascendis Pharma A/S$242.09

Frequently Asked Questions

What is the current Equillium, Inc. (EQ) stock price?

Equillium, Inc. (NASDAQ: EQ) stock price is $1.92 in the last trading session. During the trading session, EQ stock reached the peak price of $1.94 while $1.71 was the lowest point it dropped to. The percentage change in EQ stock occurred in the recent session was 5.49% while the dollar amount for the price change in EQ stock was $0.10.

EQ's industry and sector of operation?

The NASDAQ listed EQ is part of Biotechnology industry that operates in the broader Healthcare sector. Equillium, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EQ?

Ms. Maple Fung M.D.
Chief Medical Officer
Dr. Stephen Connelly Ph.D.
Chief Scientific Officer & Director
Mr. Jason A. Keyes
Chief Financial Officer
Dr. Krishna R. Polu M.D.
Consultant
Mr. Daniel Mark Bradbury
Executive Chairman
Matthew Ritter Ph.D.
Senior Vice President of Corporation Devel.
Mr. Bruce D. Steel C.F.A.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Christine Zedelmayer M.B.A., P.M.P.
Senior Vice President & Chief Operating Officer
Mr. Joel M. Rothman
Chief Devel. Officer

How EQ did perform over past 52-week?

EQ's closing price is 611.11% higher than its 52-week low of $0.27 where as its distance from 52-week high of $2.35 is -18.3%.

How many employees does EQ have?

Number of EQ employees currently stands at 35.

Link for EQ official website?

Official Website of EQ is: https://equilliumbio.com

How do I contact EQ?

EQ could be contacted at phone 858 412 5302 and can also be accessed through its website. EQ operates from 2223 Avenida De La Playa, La Jolla, CA 92037, United States.

How many shares of EQ are traded daily?

EQ stock volume for the day was 270.04K shares. The average number of EQ shares traded daily for last 3 months was 666.37K.

What is the market cap of EQ currently?

The market value of EQ currently stands at $68.20M with its latest stock price at $1.92 and 35.52M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	35
Beta	1.85
Sales or Revenue	$36.08M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	35
Beta	1.85
Sales or Revenue	$36.08M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

EQ Company Profile and Key Details

Equillium

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics